Corporate Presentation April 2016
Presentation

ASH 2015 Investor and Analyst Event
Presentation

ASH 2014 Investor and Analyst Event
Presentation

 

2015 Annual Report
Download here

 

Asterias Stock Tax Guidance
Download here

 
Webcast ImageWebcast
Geron 2016 Annual Meeting of Stockholders (Live)
05/17/16 at 7:00 p.m. ET
Geron 2016 Annual Meeting of Stockholders
Tuesday, May 17, 2016 7:00 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
Q1 2016 Geron Earnings Conference Call (Live)
05/05/16 at 1:30 p.m. PT
Q1 2016 Geron Earnings Conference Call
Thursday, May 5, 2016 1:30 p.m. PT  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Corporate Profile
Geron is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.
Recent NewsMore >>
DateTitle 
04/27/16Geron Announces Conference Call to Discuss First Quarter 2016 Financial ResultsPrinter Friendly Version
04/20/16Geron Announces Two Imetelstat Poster Presentations at the American Association for Cancer Research Annual MeetingPrinter Friendly Version
04/05/16Geron to Present at the Needham Healthcare ConferencePrinter Friendly Version
Upcoming EventsMore >>
DateTitle
05/05/16 1:30 p.m. PT
Q1 2016 Geron Earnings Conference Call
05/17/16 7:00 p.m. ET
Geron 2016 Annual Meeting of Stockholders
LocationWestin San Francisco Airport
One Old Bayshore Highway
Millbrae, CA 94030
Stock Information
GERN (Common Stock)
ExchangeNASDAQ GS (US Dollar)
Price$2.95
Change (%) Stock is Down 0.09 (2.96%)
Volume1,829,105
Data as of 04/29/16 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
  
Contact Information

Anna Krassowska, Ph.D.
Tel: 650-473-7700
E-mail: investor@geron.com or media@geron.com



RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | Financial Tear Sheet Financial Tear Sheet
Close
Form content here please :)